Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series.

Naqvi, Mohammad Faraz; Vo, Henry Hiep; Vining, David; Tsimberidou, Apostolia-Maria

Naqvi, Mohammad Faraz; Vo, Henry Hiep; Vining, David; Tsimberidou, Apostolia-Maria.

Afiliación

Naqvi MF; Department of Investigational Cancer Therapeutics, Phase I Clinical Trials Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Vo HH; Department of Investigational Cancer Therapeutics, Phase I Clinical Trials Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Vining D; Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tsimberidou AM; Department of Investigational Cancer Therapeutics, Phase I Clinical Trials Program, The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Ther Adv Med Oncol ; 13: 17588359211001538, 2021.

Article en En | MEDLINE | ID: mdl-33995588

Palabras clave

cell-free DNA; circulating tumor DNA; genomic profiling; personalized therapy; precision medicine; targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google